HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the ...
In an interview with Torbjörn Ogéus, Stockholms led- & smärtklinik (SLS), Open Access Government explores how the landscape of regenerative medicine is shifting ...